AdvaMed Aims To Make A Splash In D.C. At First Annual Conference
This article was originally published in The Gray Sheet
Executive Summary
The device industry plans to make its presence felt in Washington during the first week of October with AdvaMed's first annual international conference and exhibition
You may also be interested in...
Next AdvaMed Chief Is BIO Exec Scott Whitaker
Whitaker, appointed as the next CEO of AdvaMed, currently runs day-to-day operations at the Biotechnology Innovation Organization and has held high-level posts at HHS. Among his accomplishments, Whitaker led the legislative office at HHS when the first device user fee bill was passed in 2002.
Global Harmonization Task Force Moves Into “Implementation Mode”
Efforts to harmonize device regulations globally will see more activity over the next year if Larry Kessler has his way
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.